Clinical Trial Update: Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients [NA]

View source ↗

Summary

The cooling cap trial (NCT04678544) evaluating prevention of permanent chemotherapy-induced alopecia in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Neoplasm, Breast | NA | Status: COMPLETED